- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Harris & Harris Group Invests in Nanoopto CorporationNew York, NY | March 22, 2005
Harris & Harris Group, Inc., announced today that it
invested $842,503 as part of a $12 million Series C round of
financing by privately held NanoOpto Corporation
(www.nanoopto.com). First Analysis led the Series C financing and
existing equity partners Morgenthaler Ventures; U.S. Trust's
Excelsior Venture Partners III, L.L.C.; Draper Fisher Jurvetson
(DFJ) Gotham Ventures and New England Ventures; and Harris & Harris
Group all participated. Doug Jamison will represent Harris & Harris
Group on the board of NanoOpto. Harris & Harris Group originally
invested in NanoOpto in March 2002 and currently owns approximately
7.97 percent of the fully diluted equity in privately held NanoOpto.
####This news release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this news release. Please see the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.
Douglas W. Jamison (212) 582-0900
Copyright © Harris & Harris Group
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014